Pre-commercialization Business Development Fund

Introduction

OGI's Pre-commercialization Business Development Fund (PBDF) is a unique and useful investment fund that is helping to enable the economic impact of outcomes of genomics and proteomics research projects and technology development. Specifically, it aims to provide early-stage funding as researchers move towards commercial applications and to speed up transfer of products from lab to marketplace.  The fund invests up to $100K per project.

Please note, the PBDF is on hold for the 2013/14 fiscal year.

Specific Objectives

  • Create economic results from genomics and proteomics research;
  • Support scientific entrepreneurs;
  • Broker partnerships between academia and industry; and
  • Generate returns for future PBDF investments.

For more information, contact the Business Development team.